BILATERAL BREAST CARCINOMA
Clinical trials for BILATERAL BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BILATERAL BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for BILATERAL BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a second drug wipe out stubborn breast cancer?
Disease control OngoingThis study tests whether the drug ixabepilone can help people with HER2-negative breast cancer whose tumors didn't fully disappear after standard chemotherapy. About 116 participants will either receive ixabepilone or be observed. The goal is to see if the drug can stop cancer fr…
Matched conditions: BILATERAL BREAST CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New combo aims to outsmart resistant breast cancer
Disease control OngoingThis early-phase study tests a drug called berzosertib combined with radiation therapy for people with certain types of breast cancer that no longer respond to chemotherapy. The goal is to find the safest dose and see if the combination can shrink or stabilize tumors better than …
Matched conditions: BILATERAL BREAST CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:53 UTC